Endogenous IL-33 contributes to Treg expansion induced by IL-2/CD25, a novel IL-2 biologic developed for low-dose IL-2 therapy-MedSci.cn

Endogenous IL-33 contributes to Treg expansion induced by IL-2/CD25, a novel IL-2 biologic developed for low-dose IL-2 therapy

Lui, JBP; Malek, TR

JOURNAL OF IMMUNOLOGY, 2020; 204 (1):

科室
- - 订阅+
  - 更多科室
工具
服务